Global Emergency Contraceptive Pills Market to Reach USD 826.5 Million by 2033, Propelled by the Development of Effective and Convenient Emergency Contraceptive Pills

December 19, 2024 | Healthcare

The latest report by IMARC Group, titled “Emergency Contraceptive Pills Market Report by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2025-2033,” finds that the global emergency contraceptive pills market size reached USD 606.4 Million in 2024. Emergency contraceptive pills, or morning-after pills, are a form of birth control used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. These pills contain hormones, typically levonorgestrel or ulipristal acetate, that work by inhibiting or delaying ovulation, fertilization, or implantation of the fertilized egg into the uterus lining. For instance, one common type of emergency contraceptive pill is the levonorgestrel-based pill, available over-the-counter in many countries. It should be taken after unprotected intercourse, ideally within 72 hours, although its effectiveness decreases with time. Another option is ulipristal acetate, available with a prescription and effective up to 120 hours after unprotected sex. They are meant for occasional use when other forms of contraception fail or are not used. Additionally, emergency contraceptive pills are generally safe and have side effects such as nausea, fatigue, or changes in menstrual cycles.

Global Emergency Contraceptive Pills Market Trends:

The market is primarily driven by the significant increase in awareness and education regarding emergency contraception. In addition, public health campaigns, educational programs, and easy access to information are essential in informing individuals about the availability and proper usage of emergency contraceptive pills, thus influencing market growth. Moreover, several advances in pharmaceutical research led to the development of more effective and convenient emergency contraceptive pills, which increased consumer confidence in the products and their reliability, representing another major growth-inducing factor. Besides this, the easy availability of emergency contraceptive pills over the counter and through healthcare providers removed many barriers that previously hindered individuals from obtaining timely emergency contraception, which is accelerating the market growth. Along with this, the changing societal attitudes toward emergency contraception reduced the stigma associated with its use, allowing more individuals to discuss and seek these products, propelling the market growth. Apart from this, the implementation of several regulatory changes in some countries made it easier to access emergency contraception without a prescription, thus augmenting the market growth. Furthermore, the changing demographics, such as delayed family planning and a focus on career development, are escalating the demand for emergency contraception among women of reproductive age, thus creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach USD 826.5 Million by 2033, exhibiting a CAGR of 3.33% during the forecast period (2025-2033).

Market Summary:

  • Based on the type, the market has been categorized into combination pills, progesterone pills, and others. Presently, combination pills represent the leading segment.
  • On the basis of the distribution channel, the market has been divided into retail stores, online stores, and others. Currently, retail stores hold the leading position in the market.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. Among these, North America exhibits a clear dominance in the market.
  • The competitive landscape of the industry has also been examined in the report, with some of the key players being Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., and Syzygy Healthcare Solutions LLC.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Types Covered Combination Pills, Progesterone Pills, Others
Distribution Channels Covered Retail Stores, Online Stores, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Emergency Contraceptive Pills Market to Reach USD 826.5 Million by 2033, Propelled by the Development of Effective and Convenient Emergency Contraceptive Pills
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials